|
|
Title | Creator | Date |
1 |
|
Comments on Tocilicizumab Use in Giant Cell Arteritis | Laura Donaldson, Kirill Zaslavsky, Edward Margolin | 2022-06 |
2 |
|
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis | Arjun V Jogimahanti, Ashwini T Kini, Lauren E Irwin, Andrew G Lee | 2021-09 |
3 |
|
Diagnosing Giant Cell Arteritis: Is Ultrasound Enough? | Landau, Klara; Savino, Peter J; Gruber, Philipp | |
4 |
|
Giant Cell Arteritis | Courtney E. Francis, MD | 2016-03 |
5 |
|
The Immunopathology of Giant Cell Arteritis: Diagnostic and Therapeutic Implications | Liegel, Katharine; Feldon, Steven; Williams, Zo | |
6 |
|
Throat Pain as a Presenting Symptom of Giant Cell Arteritis | Ling, Jeanie D; Hashemi, Nafiseh; Lee, Andrew G | |
7 |
|
Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis? | Lynn K. Gordon, Alfredo A. Sadun, Greg Van Stavern, Andrew G. Lee | 2022-06 |
8 |
|
Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis | Jorge A. Uribe, MD, Ishita Aggarwal, MD, Juthamat Witthayaweerasak, MD,Y. Joyce Liao, MD, PhD, Gerald J. Berry, MD, Umesh K. Sab, MD,Cornelia M. Weyand, MD, PhD | 2018-03 |
9 |
|
Superficial temporal artery biopsy. A simplified technique. | Tomsak, R.L. | |
10 |
|
What is Vasculitis | Nadeau, Stephen E | |
11 |
|
Does Tocilizumab Influence Ophthalmic Outcomes in Giant Cell Arteritis? | Marc A. Bouffard, Sashank Prasad, Sebastian Unizony, Fiona Costello | 2022-06 |
12 |
|
Familial giant cell arteritis. | Novak, M.A.; Green, W.R.; Miller, N.R. | |
13 |
|
Bilateral Anterior Ischemic Optic Neuropathy Due to Giant Cell Arteritis With Preservation of Central Visual Acuity | Laura Donaldson, Edward Margolin | 2022-06 |
14 |
|
The Clinical Significance of Small Vessel Vasculitis on Temporal Artery Biopsies | Julian Quigley, Anthony Michael Sammel, Rodger Laurent, Janice Brewer, Edward Hsiao, Geoffrey Schembri, Clare L. Fraser | 2022-06 |
15 |
|
Jaw Claudication and Temporal Artery Abnormalities in Giant Cell Arteritis: Take Advantage of Clinical Clues: Response | Courtney E Francis, MD, Christine A Petersen, MD | 2017-12 |
16 |
|
Comment to: "Ahuja AS et al: Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis" | Francesco Pellegrini, Emanuela Interlandi, Francesco Pichi | 2022-06 |
17 |
|
Use of Retinal Angiography and MRI in the Diagnosis of Giant Cell Arteritis With Early Ophthalmic Manifestations | Alexandre Dentel, Gaelle Clavel, Julien Savatovsky, Catherine Vignal, Thomas Senè, Frédérique Charbonneau, Kevin Zuber, Augustin Lecler, Rabih Hage | 2022-06 |
18 |
|
Pellegrini et al-"Reply to: Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis": Response | Abhimanyu S. Ahuja, Mays A. El-Dairi, Majda Hadziahmetovic, Sidney M. Gospe 3rd | 2022-06 |
19 |
|
Low Diagnostic Yield with Second Biopsies in Suspected Giant Cell Arteritis | Danesh-Meyer, Helen V.; Savino, Peter J.; Eagle, Ralph C.; Kubis, Kenneth C.; Sergott, Robert C. | |
20 |
|
Horner Syndrome in Giant Cell Arteritis: Case Series and Review of the Literature | Irina Sverdlichenko, Cindy Lam, Laura Donaldson, Edward Margolin | 2022-09 |
21 |
|
Siegrist Streaks in Giant Cell Arteritis | Coupal, DJ; Patel, AD | 1994-06 |
22 |
|
Giant Cell Arteritis With Arteritic Anterior Ischemic Optic Neuropathy Is Bilateral Until Proven Otherwise | Nandini Singh, BMed, Adarsh George, BMed, Jeremy Tan, BMed, MD, Shaun Y. P. Ewe, MBBS, BMedSci, Ian C. Francis, FRACS, PhD | 2016-12 |
23 |
|
Temporal Arteritis With Arteritic Anterior Ischemic Optic Neuropathy is Bilateral Until Proven Otherwise: Response | Neil R. Miller, MD, Tin Yan Alvin Liu, MD | 2016-12 |
24 |
|
Treatment of Acute Visual Loss in Giant Cell Arteritis: Should We Prescribe High-Dose Intravenous Steroids or Just Oral Steroids? | Hayreh, Sohan Singh; Biousse, Valerie | |
25 |
|
Effect of Diabetes Mellitus on Giant Cell Arteritis | Anne S. Abel; Arseniy P. Yashkin; Frank A. Sloan; Michael S. Lee | |